| Literature DB >> 35600083 |
Abstract
Objectives: This research aims to predict the micro-vascular invasion and histopathologic grade of hepatocellular carcinoma with the CT-derived radiomics.Entities:
Keywords: CT-Radiomics; Hepatocellular carcinoma; Machine Learning; Prognostic factors
Year: 2022 PMID: 35600083 PMCID: PMC9120240 DOI: 10.1016/j.ejro.2022.100424
Source DB: PubMed Journal: Eur J Radiol Open ISSN: 2352-0477
Fig. 1Schematic flowchart.
Patients characteristics.
| Characteristics | Values | p Values (p£/p§) |
|---|---|---|
| Mean age (years) | 61.8 ± 14.0 (Min: 20, Max: 85) | 0.043£/0.021§ |
| Gender | Men (54/65.9%)/Women (28/34.1%) | 0.039£/0.044§ |
| Mean Height (cm) | 167.1 ± 13.5 (Min: 64.0, Max: 188.0) | 0.872£/0.451§ |
| Mean Weight (kg) | 78.0 ± 20.9 (Min: 47.0, Max: 129.0) | 0.542£/0.770§ |
| Race | NA (6/7.3%)/Black (3/3.7%)/White (50/61.0%)/ Asia (23/28.0%) | 0.890£/0.718§ |
| Liver Cirrhosis | With (59/72.0%)/Without (23/28.0%) | 0.072£/0.088§ |
| Tumor Burden | Unifocal (68/82.9%)/ Multifocal (14/17.1%) | 0.121£/0.205§ |
| No. of Lesions | 2.9 ± 2.3 (Min: 1.0, Max: 8.0) | 0.100£/0.151§ |
| Diameter (cm) | 5.9 ± 2.1 (Min: 1.2, Max: 14.2) | 0.080£/0.720§ |
| Segment Location | I-II (3/3.7%)/III (7/8.5%)/IV (18/22.0%)/V (13/15.9%)/VI (22/26.8%)/VII-VIII (19/23.2%) | 0.388£/0.659§ |
| Etiology | Hepatitis B virus (25/30.5%)/Hepatitis C virus (34/41.5%)/Alcohol and other (23/28.0%) | 0.062£/0.215§ |
| MVI | Negative (25/30.5%)/ Positive (57/69.5%) | 0.040£ |
| Grade | Low (53/64.6%))/High (29/35.4%) | 0.033§ |
| Alpha Fetoprotein | 7498.0 ± 13,787.0 (Min: 1.0, Max: 10,3900) | 0.022£/0.045§ |
| T Stage | T1 (35/42.7%)/T2 (16/19.5%)/T3 (7/8.5%)/T3a (9/11.0%)/T3b (8/9.8%)/T4 (7/8.5%) | 0.004£/0.002§ |
| N Stage | N0 (63/76.8%)/N1(3/3.7%)/NX (16/19.5%) | 0.101£/0.171§ |
| M Stage | M0 (68/82.9)/M1(4/4.9%)/MX (10/12.2%) | 0.235£/0.188§ |
| Child pugh classification | NA (12/14.6%)/A (53/64.6%)/B (17/20.7%) | 0.098£/0.297§ |
| ECOG Score | 0 (41/50.0%)/1 (32/39.0%)/2 (9/11.0%) | 0.132£/0.007§ |
Note: 1) NA indicates the results are unknown or unavailable. 2) p£ and p§ represent the p values for histopathologic grade and micro-vascular invasion, respectively. The p values were calculated according to the Fisher's exact test for categorical variables and the p values were calculated according to the Mann-Whitney U test for continuous variables.
Selected features for grading HCC.
| Selection strategy | Radiomics features | Category | Enhanced phase |
|---|---|---|---|
| Median | FO | VP | |
| Autocorrelation | GLCM | DP | |
| Contrast | GLCM | AP | |
| Joint Entropy | GLCM | AP | |
| Large Dependence High Gray Level Emphasis | GLCM | VP | |
| Low Gray Level Zone Emphasis (LGLZE) | GLSZM | VP | |
| Elongation | Shape | DP | |
| Median | FO | AP | |
| Autocorrelation | GLCM | VP | |
| Contrast | GLCM | VP | |
| Low Gray Level Emphasis (LGLE) | GLDM | DP | |
| Dependence Entropy (DE) | GLDM | AP | |
| Dependence Non-Uniformity (DN) | GLDM | VP | |
| Large Dependence Emphasis (LDE) | GLDM | DP | |
| Coarseness | NGTDM | AP | |
| Elongation | Shape | DP | |
| Flatness | Shape | DP |
Notes: 1) FO is the abbreviation of First-Order. 2) Enhanced phase indicates which phase of CT images the corresponding features were extracted from. 3) AP, VP, and DP represent the arterial-phase (AP), venous-phase (VP) and delay-phase (DP), respectively.
Selected features for identifying the MVI status.
| Selection strategy | Radiomics features | Category | Enhanced phase |
|---|---|---|---|
| Kurtosis | FO | AP | |
| Total Energy | FO | VP | |
| Autocorrelation | GLCM | AP | |
| Contrast | GLCM | DP | |
| Difference Entropy | GLCM | VP | |
| Low Gray Level Emphasis (LGLE) | GLDM | VP | |
| Gray Level Non-Uniformity (GLN) | GLRLM | VP | |
| Low Gray Level Zone Emphasis (LGLZE) | GLSZM | AP | |
| Small Area Low Gray Level Emphasis (SALGLE) | GLSZM | VP | |
| Coarseness | NGTDM | DP | |
| Elongation | Shape | VP | |
| Flatness | Shape | AP | |
| Spherical Disproportion | Shape | DP | |
| Mean | FO | VP | |
| Joint Average | GLCM | AP | |
| Autocorrelation | GLCM | DP | |
| Cluster Shade | GLCM | DP | |
| Difference Entropy | GLCM | VP | |
| Small Dependence Emphasis (SDE) | GLDM | VP | |
| Gray Level Non-Uniformity (GLN) | GLRLM | AP | |
| Low Gray Level Zone Emphasis (LGLZE) | GLSZM | VP | |
| Zone Percentage (ZP) | GLSZM | DP | |
| Spherical Disproportion | Shape | AP |
Notes: 1) FO is the abbreviation of First-Order. 2) Enhanced phase indicates which phase of CT images the corresponding features were extracted from. 3) AP, VP, and DP represent the arterial-phase (AP), venous-phase (VP) and delay-phase (DP), respectively.
Diagnostic performance of radiomics-based models.
| Feature | Classifier | Fold1 | Fold2 | Fold3 | Fold4 | Fold5 | Mean | |
|---|---|---|---|---|---|---|---|---|
| Grade | LASSO | SVM | 0.625 | 0.625 | 0.686 | 0.667 | 0.586 | 0.638 |
| Grade | SVM-RFE | SVM | 0.800 | 0.667 | 0.700 | 0.778 | 0.729 | 0.735 |
| Grade | LASSO | RF | 0.806 | 0.686 | 0.815 | 0.778 | 0.639 | 0.745 |
| Grade | SVM-RFE | RF | 0.906 | 0.917 | 0.857 | 0.938 | 0.875 | 0.898 |
| MVI | LASSO | SVM | 0.611 | 0.667 | 0.667 | 0.833 | 0.625 | 0.681 |
| MVI | SVM-RFE | SVM | 0.833 | 0.833 | 0.833 | 0.833 | 0.750 | 0.817 |
| MVI | LASSO | RF | 0.889 | 0.926 | 0.889 | 0.800 | 0.875 | 0.876 |
| MVI | SVM-RFE | RF | 0.624 | 0.762 | 0.715 | 0.78 | 0.812 | 0.721 |
Note: The values are the AUC values.
Fig. 2Diagnostic performance of best radiomics-based models for evaluating the tumor grade and MVI.
Fig. 3Categorical distribution of best feature subset for assessing tumor grade (first row) and MVI (second row).
Fig. 4Value distribution of selected features in different subgroups (High Grade, Low Grade, MVI (+), MVI (-)). Note: 1) A grid in the longitudinal direction represents a patient. A grid on the horizontal represents a feature. 2) Only the best feature subsets for assessing the tumor grade and MVI are displayed.
Determine independent clinical risk factor for histopathologic grade and micro-vascular invasion.
| Histopathologic Grade | |||
|---|---|---|---|
| Clinical Variables | Coefficients | SD | |
| Age | 1.256 | 0.413 | 0.045 |
| Gender | 0.523 | 0.348 | 0.037 |
| AFP | 0.274 | 0.080 | 0.029 |
| Tumor Stage | 1.767 | 0.692 | 0.002 |
| MVI | |||
| Clinical Variables | Coefficients | SD | |
| Age | 1.075 | 0.621 | 0.030 |
| Gender | 0.481 | 0.256 | 0.041 |
| AFP | 0.188 | 0.092 | 0.048 |
| Tumor Stage | 1.583 | 0.871 | 0.011 |
| Ecog Score | 1.989 | 0.674 | 0.005 |
Fig. 5Nomogram-based predictor for grading HCC and the diagnostic performance comparison.
Fig. 6Nomogram-based predictor for identifying MVI status and the diagnostic performance comparison.
Diagnostic performance evaluation and comparison.
| Model Evaluation | ||||
|---|---|---|---|---|
| Sensitivity (%) | Specificity (%) | AUC | Youden index | |
| Grade | ||||
| Clinical Model | 85.0 | 61.0 | 0.731 | 0.460 |
| Radiomics Model | 90.0 | 80.5 | 0.876 | 0.705 |
| Nomogram Predictor | 80.0 | 95.1 | 0.928 | 0.751 |
| MVI | ||||
| Clinical Model | 95.0 | 56.1 | 0.716 | 0.511 |
| Radiomics Model | 95.0 | 70.3 | 0.890 | 0.657 |
| Nomogram Predictor | 95.0 | 80.5 | 0.945 | 0.755 |
| Grade | ||||
| Radiomics Model | 0.005 | |||
| 0.002 | ||||
| 0.038 | ||||
| 0.002 | ||||
| 0.001 | ||||
| 0.045 | ||||
Note: The model highlighted by red color is the better model compared to the other model.